{{Rsnum
|rsid=3213448
|Gene=IL1RN
|Chromosome=2
|position=113121720
|Orientation=plus
|GMAF=0.2893
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL1RN
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 22.1 | 77.0
| HCB | 35.0 | 46.0 | 19.0
| JPT | 31.9 | 54.9 | 13.3
| YRI | 8.2 | 44.9 | 46.9
| ASW | 1.8 | 35.1 | 63.2
| CHB | 35.0 | 46.0 | 19.0
| CHD | 33.3 | 51.9 | 14.8
| GIH | 1.0 | 18.8 | 80.2
| LWK | 7.3 | 40.9 | 51.8
| MEX | 1.7 | 25.9 | 72.4
| MKK | 5.8 | 44.9 | 49.4
| TSI | 0.0 | 21.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20178882
|Title=Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes
}}

{{PMID Auto
|PMID=18451331
|Title=Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.
|OA=1
}}

{{PMID Auto
|PMID=19567509
|Title=Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
|OA=1
}}

{{PMID Auto
|PMID=19729864
|Title=Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study.
|OA=1
}}

{{PMID Auto
|PMID=21205020
|Title=Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}